NVIDIA’s push into the life sciences sector has been rewarded by a wide-ranging deal with Roche’s Genentech subsidiary aimed at accelerating the use of generative artifici
Novo Nordisk has paid $60 million to partner Valo Health on a project that will apply the US start-up’s artificial intelligence-powered drug discovery engine to find new t
In this episode of the pharmaphorum podcast, editor-in-chief Jonah Comstock catches up with Adityo Prakash, CEO of Verseon, to shed some light on what the potential of AI in drug discovery